Global Anti-tumor Drug Competitive Landscape Professional Research Report 2025
Research Summary
An anti-tumor drug is a type of medication used to treat cancer by either stopping or slowing down the growth of cancer cells. They work by targeting specific molecules or processes that are essential for the growth and survival of cancer cells. Anti-tumor drugs can be administered through injections, tablets, capsules, or intravenous infusions. They can be used alone or in combination with other treatments like radiation therapy or surgery. Examples of anti-tumor drugs include chemotherapy agents, immunotherapy agents, targeted therapy agents, and hormone therapies. The choice of the drug will depend on the type of cancer and the stage of the disease.
According to DIResearch's in-depth investigation and research, the global Anti-tumor Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Anti-tumor Drug include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co, Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Anti-tumor Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anti-tumor Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anti-tumor Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anti-tumor Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Anti-tumor Drug Include:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Anti-tumor Drug Product Segment Include:
Cytotoxic Drugs
Non-cytotoxic Drugs
Anti-tumor Drug Product Application Include:
Alkylating Agents
Anti-Metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline Antitumor Drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Anti-tumor Drug Industry PESTEL Analysis
Chapter 3: Global Anti-tumor Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Anti-tumor Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Anti-tumor Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Anti-tumor Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Anti-tumor Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Anti-tumor Drug Product by Type
- 1.2.1 Cytotoxic Drugs
- 1.2.2 Non-cytotoxic Drugs
- 1.3 Anti-tumor Drug Product by Application
- 1.3.1 Alkylating Agents
- 1.3.2 Anti-Metabolism Drugs
- 1.3.3 Platinum Antineoplastic Agents
- 1.3.4 Anthracycline Antitumor Drugs
- 1.3.5 Microtubule Stabilizer
- 1.3.6 Endocrine Therapy Drugs
- 1.3.7 Immunotherapy Drugs
- 1.3.8 Gene Therapy Drugs
- 1.3.9 Targeted Antineoplastic Drugs
- 1.4 Global Anti-tumor Drug Market Size Analysis (2020-2032)
- 1.5 Anti-tumor Drug Market Development Status and Trends
- 1.5.1 Anti-tumor Drug Industry Development Status Analysis
- 1.5.2 Anti-tumor Drug Industry Development Trends Analysis
- 2 Anti-tumor Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Anti-tumor Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Anti-tumor Drug Market Analysis by Regions
- 4.1 Anti-tumor Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Anti-tumor Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Anti-tumor Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Anti-tumor Drug Revenue Forecast by Region (2026-2032)
- 5 Global Anti-tumor Drug Market Size by Type and Application
- 5.1 Global Anti-tumor Drug Market Size by Type (2020-2032)
- 5.2 Global Anti-tumor Drug Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Anti-tumor Drug Market Size by Type
- 6.4 North America Anti-tumor Drug Market Size by Application
- 6.5 North America Anti-tumor Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Anti-tumor Drug Market Size by Type
- 7.4 Europe Anti-tumor Drug Market Size by Application
- 7.5 Europe Anti-tumor Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Anti-tumor Drug Market Size by Type
- 8.4 China Anti-tumor Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Anti-tumor Drug Market Size by Type
- 9.4 APAC (excl. China) Anti-tumor Drug Market Size by Application
- 9.5 APAC (excl. China) Anti-tumor Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Anti-tumor Drug Market Size by Type
- 10.4 Latin America Anti-tumor Drug Market Size by Application
- 10.5 Latin America Anti-tumor Drug Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Anti-tumor Drug Market Size by Type
- 11.4 Middle East & Africa Anti-tumor Drug Market Size by Application
- 11.5 Middle East & Africa Anti-tumor Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Anti-tumor Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Anti-tumor Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Anti-tumor Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Roche
- 13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Roche Anti-tumor Drug Product Portfolio
- 13.1.3 Roche Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Novartis
- 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Novartis Anti-tumor Drug Product Portfolio
- 13.2.3 Novartis Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Celgene
- 13.3.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Celgene Anti-tumor Drug Product Portfolio
- 13.3.3 Celgene Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Bristol-Myers Squibb
- 13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Portfolio
- 13.4.3 Bristol-Myers Squibb Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Amgen
- 13.5.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Amgen Anti-tumor Drug Product Portfolio
- 13.5.3 Amgen Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Johnson & Johnson
- 13.6.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Johnson & Johnson Anti-tumor Drug Product Portfolio
- 13.6.3 Johnson & Johnson Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Pfizer
- 13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Pfizer Anti-tumor Drug Product Portfolio
- 13.7.3 Pfizer Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Takeda
- 13.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Takeda Anti-tumor Drug Product Portfolio
- 13.8.3 Takeda Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Eli Lilly
- 13.9.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Eli Lilly Anti-tumor Drug Product Portfolio
- 13.9.3 Eli Lilly Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 AstraZeneca
- 13.10.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 AstraZeneca Anti-tumor Drug Product Portfolio
- 13.10.3 AstraZeneca Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Astellas
- 13.11.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Astellas Anti-tumor Drug Product Portfolio
- 13.11.3 Astellas Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Merck & Co
- 13.12.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Merck & Co Anti-tumor Drug Product Portfolio
- 13.12.3 Merck & Co Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Sanofi
- 13.13.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Sanofi Anti-tumor Drug Product Portfolio
- 13.13.3 Sanofi Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Bayer
- 13.14.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Bayer Anti-tumor Drug Product Portfolio
- 13.14.3 Bayer Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Biogen Idec
- 13.15.1 Biogen Idec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Biogen Idec Anti-tumor Drug Product Portfolio
- 13.15.3 Biogen Idec Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Eisai
- 13.16.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Eisai Anti-tumor Drug Product Portfolio
- 13.16.3 Eisai Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Teva
- 13.17.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Teva Anti-tumor Drug Product Portfolio
- 13.17.3 Teva Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 Otsuka
- 13.18.1 Otsuka Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Otsuka Anti-tumor Drug Product Portfolio
- 13.18.3 Otsuka Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Anti-tumor Drug Industry Chain Analysis
- 14.2 Anti-tumor Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Anti-tumor Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Anti-tumor Drug Typical Downstream Customers
- 14.4 Anti-tumor Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook